Prognostic Factors for OS According to Cox Uni- and Multivariate Analysis
| Univariate analysis | Multivariate analysis | |||||
| Model 1 | Model 2 | |||||
| Variable | Hazard ratio | P | Hazard ratio | P | Hazard ratio | P |
| Age at diagnosis (y) | 1.001 (0.94–1.08) | 0.752 | ||||
| 18F-FDG SUV (≥8.28) | 5.693 (0.66–48.92) | 0.113 | ||||
| 18F-FES SUV (<2.63) | 15.306 (1.79–131.12) | 0.013* | 4.982 (0.42–59.05) | 0.203 | ||
| 18F-FDG/FES SUV ratio (≥4.23) | 28.661 (3.31–248.10) | 0.002* | 8.998 (0.78–104.44) | 0.079 | ||
| FIGO stage (stage III–IV) | 26.942 (3.13–231.90) | 0.003* | 12.866 (1.09–152.35) | 0.043* | 7.535 (0.56–100.69) | 0.127 |
| Histopathologic type (G3 and other) | 531.672 (0.02–16,142,371.35) | 0.233 | ||||
| Myometrial invasion (≥1/2) | 5.252 (0.96–28.71) | 0.056 | ||||
| LVSI (present) | 155.323 (0.11–226,818.17) | 0.175 | ||||
| Tumor size (≥2 cm) | 45.064 (0.05–41,088.27) | 0.273 | ||||
| Lymph node metastasis (present) | 14.187 (2.75–73.11) | 0.002* | 1.005 (0.15–6.98) | 0.996 | 1.432 (0.22–9.27) | 0.706 |
↵* P < 0.05.
Data in parentheses are 95% CIs.